跳至主要内容
临床试验/NCT05014035
NCT05014035已完成不适用

Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer

University of South Carolina2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
Retention

研究概览

简要总结

Symptom burden remains a critical concern for individuals with non-small cell lung cancer (NSCLC) following the completion of treatment. Of those, symptom clusters such as dyspnea (shortness of breath) and fatigue, contribute to physical decline, reductions in quality of life, and a higher risk of comorbidities and mortality. It has been proposed that dyspnea is a primary limiter of exercise capacity in individuals with lung cancer, resulting in exercise avoidance and an accelerated physical decline. As such, specifically designing resistance exercise programs with cluster sets, to mitigate feelings of dyspnea and fatigue may result in improved exercise tolerance, resulting in the maintenance of physical function and quality of life.

The purpose of this project is to investigate the feasibility and preliminary efficacy of a hybrid-delivery of home-based cluster-set resistance exercise in individuals with NSCLC. Methods: Individuals with NSCLC (n=15), within 12-months of completion of treatment will be recruited to participate in this single arm feasibility trial. Participants will complete 8-weeks of home-based resistance training (RT) designed to target dyspnea and fatigue. The hybrid-delivery of the program will include supervised sessions in the participants home, and virtual supervision via video conferencing. The primary outcome of feasibility will be measured via recruitment rates, retention, acceptability and intervention fidelity. Exploratory outcomes (dyspnea, fatigue, quality of life, physical function and body composition) will be assessed pre- and post- intervention.

详细描述

Analysis plan. Descriptive statistics (percentages and means (with standard deviations)) will be used to report on feasibility outcomes (recruitment, retention, fidelity etc.). Unless explicitly stated, means and standard deviations will be reported for assessments of exploratory outcomes at baseline and follow-up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Completed definitive treatment for localized NSCLC (stages I-III)
  • Has access to stable internet access for Zoom participation
  • Willing to complete an 8-week, home-based intervention program that includes face-to-face and Zoom interaction.
  • Willing to consider behavior change at this time.
  • Able to speak and read English.
  • Capable of informed consent
  • Has obtained medical clearance from medical practitioner or medical team

排除标准

  • Individuals with a known diagnosis of advanced lung cancer (stage IV; due to potential added burden) or diagnosis of small-cell lung cancer,
  • Anyone for whom physical activity is not recommended.
  • aren't comfortable having study staff visit their homes for exercise sessions
  • have any neuromuscular, cardiovascular, or psychological condition precluding safe exercise;
  • have participated in structured RE ≥2 times/week for the past 6 months;
  • are unable to read/understand English.

结局指标

主要结局

Retention

时间窗: Through study completion, an average of 1 year

If ≥75% of the sample recruited to participate return for follow up testing

Intervention Fidelity

时间窗: Through study completion, an average of 1 year

Exercise fidelity will be reported using metrics previously outlines by Fairman et al (2019). Specifically, volume load will be calculated as a function of sets x reps for each exercise and summed to give total volume for each session. We will report the proportion of volume achieved relevant to what was prescribed to give a "relative-dose intensity" (RDI) for each person. RDI will then be averaged and used to determine fidelity to the RT intervention.

Recruitment

时间窗: Through study completion, an average of 1 year

The recruitment goal of n=15 is reached

次要结局

  • Lower Body Muscular Strength(Baseline and post intervention (8-weeks))
  • Bone Mineral Density(Baseline and post intervention (8-weeks))
  • Dyspnea(Baseline and post intervention (8-weeks))
  • Acceptability(Post-Intervention (8-weeks))
  • Fatigue(Baseline and post intervention (8-weeks))
  • Physical Function STS(Baseline and post intervention (8-weeks))
  • Total Mass(Baseline and post intervention (8-weeks))
  • Appendicular Lean Mass(Baseline and post intervention (8-weeks))
  • Lung Cancer Related Quality of Life(Baseline and post intervention (8-weeks))
  • Upper Body Muscular Strength(Baseline and post intervention (8-weeks))
  • Physical Function 6MWT(Baseline and post intervention (8-weeks))
  • Fat Mass(Baseline and post intervention (8-weeks))
  • Fat Free Mass(Baseline and post intervention (8-weeks))
  • Body Fat Percentage(Baseline and post intervention (8-weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ciaran Fairman

Assistant Professor

University of South Carolina

研究点 (2)

Loading locations...

相似试验